{"id":"https://openalex.org/W68341129","doi":null,"title":"Gender differences of ADRs related to psychotropic drug: a survey from Italy, France and Spain","display_name":"Gender differences of ADRs related to psychotropic drug: a survey from Italy, France and Spain","publication_year":2011,"publication_date":"2011-01-26","ids":{"openalex":"https://openalex.org/W68341129","mag":"68341129"},"language":"en","primary_location":{"id":"pmh:oai:www.research.unipd.it:11577/3427468","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/11577/3427468","pdf_url":null,"source":{"id":"https://openalex.org/S4306402547","display_name":"Padua Research Archive (University of Padova)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I138689650","host_organization_name":"University of Padua","host_organization_lineage":["https://openalex.org/I138689650"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/doctoralThesis"},"volume":null,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://hdl.handle.net/11577/3427468","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064565532","display_name":"Paola D\u2019Incau","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Paola D\u2019Incau","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5064565532"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13252","display_name":"Sex and Gender in Healthcare","score":0.007600000128149986,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gender-differences","display_name":"gender differences","score":0.7300000190734863},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.9660000205039978},{"id":"https://openalex.org/keywords/psychotropic-drugs","display_name":"psychotropic drugs","score":0.9990000128746033},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.7680000066757202},{"id":"https://openalex.org/keywords/anxiolytics","display_name":"anxiolytics","score":0.8339999914169312},{"id":"https://openalex.org/keywords/hypnotics","display_name":"hypnotics","score":0.9390000104904175},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.9900000095367432},{"id":"https://openalex.org/keywords/stimulants","display_name":"stimulants","score":0.8669999837875366},{"id":"https://openalex.org/keywords/spontaneous-adverse-drug-reports","display_name":"spontaneous adverse drug reports","score":0.6069999933242798},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.8830000162124634},{"id":"https://openalex.org/keywords/sex-differences-in-drug-response","display_name":"sex differences in drug response","score":0.7020000219345093},{"id":"https://openalex.org/keywords/reporting-odds-ratio","display_name":"reporting odds ratio","score":0.6460000276565552},{"id":"https://openalex.org/keywords/women-s-health","display_name":"women's health","score":0.32499998807907104},{"id":"https://openalex.org/keywords/france","display_name":"France","score":0.9980000257492065},{"id":"https://openalex.org/keywords/spain","display_name":"Spain","score":0.9990000128746033},{"id":"https://openalex.org/keywords/midi-pyrenees","display_name":"Midi-Pyr\u00e9n\u00e9es","score":0.9020000100135803},{"id":"https://openalex.org/keywords/veneto","display_name":"Veneto","score":0.9980000257492065},{"id":"https://openalex.org/keywords/castile-and-leon","display_name":"Castilla y Le\u00f3n","score":0.9610000252723694}],"concepts":[{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.8418734073638916},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7918218374252319},{"id":"https://openalex.org/C2993714069","wikidata":"https://www.wikidata.org/wiki/Q3706669","display_name":"Psychotropic drug","level":3,"score":0.5874402523040771},{"id":"https://openalex.org/C107130276","wikidata":"https://www.wikidata.org/wiki/Q133805","display_name":"Epidemiology","level":2,"score":0.5221377015113831},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5210592150688171},{"id":"https://openalex.org/C2993432071","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Drug reaction","level":3,"score":0.5013687610626221},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.48775774240493774},{"id":"https://openalex.org/C23276603","wikidata":"https://www.wikidata.org/wiki/Q158230","display_name":"Pharmacoepidemiology","level":3,"score":0.48474714159965515},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.4486914277076721},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.34554922580718994},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2507142424583435},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.22556015849113464},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2103155255317688},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:www.research.unipd.it:11577/3427468","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/11577/3427468","pdf_url":null,"source":{"id":"https://openalex.org/S4306402547","display_name":"Padua Research Archive (University of Padova)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I138689650","host_organization_name":"University of Padua","host_organization_lineage":["https://openalex.org/I138689650"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/doctoralThesis"},{"id":"mag:68341129","doi":null,"is_oa":false,"landing_page_url":"http://paduaresearch.cab.unipd.it/3459/","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"pmh:oai:www.research.unipd.it:11577/3427468","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/11577/3427468","pdf_url":null,"source":{"id":"https://openalex.org/S4306402547","display_name":"Padua Research Archive (University of Padova)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I138689650","host_organization_name":"University of Padua","host_organization_lineage":["https://openalex.org/I138689650"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/doctoralThesis"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":73,"referenced_works":["https://openalex.org/W39025192","https://openalex.org/W72861659","https://openalex.org/W1480454513","https://openalex.org/W1605569202","https://openalex.org/W1608258930","https://openalex.org/W1718988152","https://openalex.org/W1967526232","https://openalex.org/W1969240609","https://openalex.org/W1973975951","https://openalex.org/W1976021499","https://openalex.org/W1976401835","https://openalex.org/W1977169712","https://openalex.org/W1993245082","https://openalex.org/W1998281337","https://openalex.org/W2002814529","https://openalex.org/W2007183661","https://openalex.org/W2007567519","https://openalex.org/W2009946798","https://openalex.org/W2013936484","https://openalex.org/W2024505698","https://openalex.org/W2025021427","https://openalex.org/W2025257299","https://openalex.org/W2025706837","https://openalex.org/W2031479780","https://openalex.org/W2035326381","https://openalex.org/W2038893037","https://openalex.org/W2043830713","https://openalex.org/W2051008425","https://openalex.org/W2051148718","https://openalex.org/W2052920524","https://openalex.org/W2055483647","https://openalex.org/W2060593642","https://openalex.org/W2062407075","https://openalex.org/W2066650091","https://openalex.org/W2070789367","https://openalex.org/W2072131155","https://openalex.org/W2072522556","https://openalex.org/W2072674642","https://openalex.org/W2074127695","https://openalex.org/W2077322745","https://openalex.org/W2079126110","https://openalex.org/W2082424895","https://openalex.org/W2082587665","https://openalex.org/W2082854253","https://openalex.org/W2083003676","https://openalex.org/W2084534763","https://openalex.org/W2086564149","https://openalex.org/W2088058460","https://openalex.org/W2094026162","https://openalex.org/W2101457551","https://openalex.org/W2108505178","https://openalex.org/W2109687514","https://openalex.org/W2111967728","https://openalex.org/W2114053294","https://openalex.org/W2114691160","https://openalex.org/W2117200901","https://openalex.org/W2119502609","https://openalex.org/W2121098019","https://openalex.org/W2124074564","https://openalex.org/W2125442151","https://openalex.org/W2136769289","https://openalex.org/W2140731180","https://openalex.org/W2144152495","https://openalex.org/W2148619783","https://openalex.org/W2150968603","https://openalex.org/W2154020881","https://openalex.org/W2154495710","https://openalex.org/W2157107661","https://openalex.org/W2161925892","https://openalex.org/W2167717639","https://openalex.org/W2329904038","https://openalex.org/W2413095239","https://openalex.org/W2543964405"],"related_works":["https://openalex.org/W2129122186","https://openalex.org/W2090909991","https://openalex.org/W2574179918","https://openalex.org/W2617757413","https://openalex.org/W4367852854","https://openalex.org/W4417295040","https://openalex.org/W1966285032","https://openalex.org/W2909948739","https://openalex.org/W2935014396","https://openalex.org/W2022817684"],"abstract_inverted_index":{"Background:":[0],"It":[1,36],"is":[2,43,162,531],"well":[3,118],"recognized":[4],"that":[5,23,41,73,207,272,528],"being":[6,273],"female":[7,45,100,136,306,442,529],"appears":[8],"to":[9,27,102,163,229,248,254,518,541,545,552,571],"be":[10,550],"a":[11,44,281,494,519,532],"risk":[12,134,533,565],"factor":[13,534],"for":[14,131,341,353,361,371,535],"developing":[15],"ADRs.":[16],"A":[17,99,293],"number":[18,49],"of":[19,50,62,65,76,104,153,159,171,181,197,236,239,257,260,268,295,316,331,334,386,397,405,412,420,428,465,513,538,558],"studies":[20],"clearly":[21],"suggest":[22],"ADRs":[24,51,174,198,250,269,387,466,516,539],"are":[25,138,265],"50%":[26],"75%":[28],"more":[29,80,91],"likely":[30],"in":[31,34,47,70,114,123,135,176,300,439,468,487,515,569,578],"women":[32,83,148,168,342,470],"than":[33,84,271],"men.":[35,85],"has":[37],"also":[38,577],"been":[39],"suggested":[40],"there":[42],"preponderance":[46],"the":[48,59,63,74,129,165,177,194,216,224,231,234,245,249,263,301,317,329,389,398,406,413,421,429,434,511,536,554],"experienced":[52],"with":[53,233,286,437,441,452],"nervous":[54,478],"system":[55,479],"agents.":[56],"Results":[57],"from":[58,110],"European":[60],"Study":[61],"Epidemiology":[64],"Mental":[66],"disorders":[67],"(ESEMED)":[68],"conducted":[69],"2001-2003,":[71],"highlight":[72],"use":[75,152,330],"psychotropic":[77,154,172,237,258,332,542],"drugs":[78,173,259,392,543],"was":[79,227,277,320,338],"prevalent":[81],"among":[82,147],"Anxiolytics,":[86],"sedatives":[87],"and":[88,97,126,169,186,205,212,219,241,262,307,336,373,425,448,451,458,482,500,523,574,583],"hypnotics":[89],"were":[90,208,244,298,305,310,393,444,455,472,491],"often":[92],"used,":[93],"followed":[94],"by":[95,279],"antidepressants":[96,344],"antipsychotics.":[98],"propensity":[101],"experience":[103],"drug":[105,115,124,145,556],"adverse":[106,144],"effects":[107],"may":[108],"result":[109],"\u201cgender\u201d":[111],"related":[112,121,251,540],"differences":[113,122],"exposure":[116,235],"as":[117,119,474,493],"\u201csex\u201d":[120],"pharmacokinetics":[125,573],"pharmacodynamics.":[127],"Nonetheless,":[128],"reasons":[130],"this":[132,160],"increased":[133],"patients":[137,297],"not":[139,567],"entirely":[140],"clear,":[141],"notably":[142],"whether":[143],"reactions":[146],"reflect":[149],"an":[150],"inappropriate":[151],"medications.":[155],"Objective:":[156],"The":[157,275,326,461,506],"aim":[158],"study":[161,318,508],"analyze":[164],"difference":[166],"between":[167,210,328],"men":[170,489],"reported":[175,191,209,467,517],"regional":[178,520],"pharmacovigilance":[179],"centre":[180],"Midi-Pyre\u0301ne\u0301es":[182],"(France),":[183],"Veneto":[184],"(Italy)":[185],"Castilla-Leon":[187],"(Spain)":[188],"using":[189],"spontaneously":[190],"reactions.":[192],"Specifically":[193],"spontaneous":[195],"reports":[196,246,267,385,471,490],"studied":[199],"regarded":[200],"antipsychotics,":[201],"anxiolytics,":[202],"hypnotics,":[203],"antidepressant":[204],"stimulants":[206],"2007":[211],"2009.":[213],"Methods:":[214],"Within":[215],"French,":[217,521],"Italian":[218,522],"Spanish":[220],"Pharmacovigilance":[221,525],"System":[222],"databases,":[223],"case/non-case":[225],"method":[226],"used":[228],"measure":[230],"association":[232,276,327],"medications":[238,333],"interest":[240,261,335],"gender.":[242],"Cases":[243],"corresponding":[247],"at":[252],"least":[253],"one":[255],"type":[256,464],"non-cases":[264],"all":[266,384,469,488],"other":[270],"studied.":[274],"estimated":[278],"calculating":[280],"reporting":[282],"odds":[283],"ratio":[284],"(ROR)":[285],"its":[287],"95%":[288,348,356,365,376],"confidence":[289],"interval":[290],"(CI).":[291],"Results:":[292],"total":[294,399,407,414,422,430],"967":[296],"included":[299],"study,":[302],"592":[303],"(61%)":[304],"375":[308],"(39%)":[309],"male":[311,453],"(p<":[312],"0,001).":[313],"Mean":[314],"age":[315,362,372],"population":[319],"51":[321],"years":[322],"(range":[323],"08-97":[324],"years).":[325],"gender":[337,514],"statistically":[339],"significant":[340],"taking":[343,561],"(ROR":[345],"crude":[346],"=1.67;":[347],"CI":[349,357,366,377],"1,35-2,06;":[350],"ROR":[351,359,369],"stratified":[352,360,370],"seriousness":[354,374],"=1,71;":[355],"1,39-2,11;":[358],"=":[363],"1,53;":[364],"1,24-":[367],"1,90;":[368],"=1.54;":[375],"1,25-1,90)":[378],"[all":[379],"p":[380],"<":[381],"0,001].":[382],"Analyzing":[383],"reported,":[388],"most":[390,435,462],"involved":[391],"risperidone":[394],"(14":[395,403],"%":[396,404,419],"N05A":[400],"drugs),":[401,409,416,432],"alprazolam":[402],"N05B":[408],"zolpidem":[410],"(32%":[411],"N05C":[415],"paroxetine":[417],"(16":[418],"N06A":[423],"drugs)":[424],"methylphenidate":[426],"(39%":[427],"N06B":[431],"while":[433,486],"associated":[436],"sex,":[438,443],"particular":[440],"lithium":[445],"carbonate":[446],"(p<0.05)":[447,457],"prazepam":[449],"(p<0.05),":[450],"sex":[454,530],"clozapine":[456],"sertraline":[459],"(p<0.05).":[460],"frequent":[463],"classified":[473],"\u201cCentral":[475],"&":[476],"peripherical":[477],"disorders\u201d":[480,484,498,503],"(24%)":[481],"\u201cPsychiatric":[483],"(18%),":[485],"\u201cBody":[492],"whole":[495],"-":[496],"general":[497],"(14%)":[499],"\u201cResistance":[501],"mechanism":[502],"(13%).":[504],"Conclusions:":[505],"present":[507],"which":[509],"investigated":[510],"role":[512],"Spain":[524],"centres":[526],"indicates":[527],"development":[537],"especially":[544],"antidepressants.":[546],"Further":[547],"research":[548],"should":[549],"performed":[551],"investigate":[553],"sex-specific":[555],"safety":[557],"psychtropic":[559],"use,":[560],"into":[562],"account":[563],"potential":[564],"factors,":[566],"only":[568],"relation":[570],"pharmacogenetics,":[572],"pharmacodynamics,":[575],"but":[576],"psychological,":[579],"social,":[580],"economic,":[581],"political":[582],"cultural":[584],"aspects.":[585]},"counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}